prevention of cervical cancer / control / passive surveillance systems / prevention of vaginal and vulvar cancers / Prevention of the following diseases / /
MedicalCondition
related disease / vulvar and vaginal cancer / HPV infection / Genital warts / vulvar and vaginal squamous cell cancers / CIN / respective carcinomas / Adenocarcinoma / Papillomavirus (HPV) infection / cancers / vulvar and vaginal carcinomas / Cancer / Cervical intraepithelial neoplasia grade / disease / prevalent infection / HPV / Cervical Cancer / vaccine and non-vaccine HPV type infection / well-differentiated vulvar cancer / vulvar cancer / Cervical intraepithelial neoplasia / additional cervical and external genital disease / development genital disease / diseases / vulvar and vaginal cancers / infection / vaginal cancer / vaginal and vulvar cancers / ANY HPV infection / /
MedicalTreatment
vaccination / /
Organization
Vaccines Research and Review Center for Biologics Evaluation and Research Food and Drug Administration Subject / Food and Drug Administration / Center for Drugs / Vaccines Research and Review Center for Biologics Evaluation / Division of Vaccines / Division of Reproductive and Urologic Products / Related Products Applications office of Vaccines Research / European Union / Vaccines and Related Products Applications office of Vaccines Research / Vaccines and Related Biological Products Advisory Committee / /
Person
Douglas Pratt / Gerald Willett / M. Srodon / Andrea Sutherland / Joseph Toerner / Nancy B. Miller / Elizabeth Valenti Martha Lee / /
Position
investigator / Team Leader / Physician / General Information Product Applicant Pharmacologic Category / updated Physician / Medical Officer / /
Product
sodium chloride / Safety Immunogenicity Human Carcinogenicity / BLA / VLP / BLA supplement / Gardasil® / HPV-015 / Gardasil / HPV-007 / /
Clinical Review Memo of BLA Supplement for Human Papillomavirus Vaccine